CYYNF
Price:
$0.2225
Market Cap:
$63.30M
Cynata Therapeutics Limited, an Australian biotechnology company headquartered in Cremorne, specializes in developing and bringing to market its unique Cymerus™ mesenchymal stem cell (MSC) technology for a wide array of human therapeutic applications. Its most advanced therapeutic candidate, CYP-001, has successfully completed Phase I clinical trials addressing graft-versus-host disease (GvHD). Beyond this, its development pipeline features CYP-004, currently in Phase III clinical trials for osteoarthritis, and CYP-006TK, an innovative polymer-coated silicon wound dressing designed for diabetic wounds. The company is also actively investigating treatments for numerous other medical condition...[Read more]
Industry
Biotechnology
IPO Date
2015-05-26
Stock Exchange
OTC
Ticker
CYYNF
According to Cynata Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -7.42. This represents a change of 103.04% compared to the average of -3.65 of the last 4 quarters.
The mean historical PE Ratio of Cynata Therapeutics Limited over the last ten years is -10.27. The current -7.42 PE Ratio has changed 7.13% with respect to the historical average. Over the past ten years (40 quarters), CYYNF's PE Ratio was at its highest in in the June 2007 quarter at 0. The PE Ratio was at its lowest in in the December 2021 quarter at -17.26.
Average
-10.27
Median
-9.02
Minimum
-27.07
Maximum
-1.27
Discovering the peaks and valleys of Cynata Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 328.09%
Maximum Annual PE Ratio = -1.27
Minimum Annual Increase = -86.59%
Minimum Annual PE Ratio = -27.07
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.27 | -39.80% |
| 2024 | -5.44 | 328.09% |
| 2023 | -1.27 | -86.59% |
| 2022 | -9.47 | 10.59% |
| 2021 | -8.57 | -51.11% |
| 2020 | -17.52 | 18.48% |
| 2019 | -14.79 | -45.38% |
| 2018 | -27.07 | 152.38% |
| 2017 | -10.73 | 135.88% |
| 2016 | -4.55 | -69.90% |
The current PE Ratio of Cynata Therapeutics Limited (CYYNF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.33
5-year avg
-5.60
10-year avg
-10.27
Cynata Therapeutics Limited’s PE Ratio is greater than MedMira Inc. (-12.98), less than Sernova Corp. (-4.30), less than Defence Therapeutics Inc. (-5.02), less than Provectus Biopharmaceuticals, Inc. (-4.56), greater than Drug Free Solution, Inc. (-8.47), greater than Medical Developments International Limited (-99.48), less than Novacyt S.A. (-0.55), less than Oncotelic Therapeutics, Inc. (0.09), greater than Vivos Inc. (-8.79), less than The Cannabist Company Holdings Inc. (-0.08),
| Company | PE Ratio | Market cap |
|---|---|---|
| -12.98 | $8.49M | |
| -4.30 | $38.25M | |
| -5.02 | $23.03M | |
| -4.56 | $25.64M | |
| -8.47 | $88.89K | |
| -99.48 | $41.68M | |
| -0.55 | $34.77M | |
| 0.09 | $22.22M | |
| -8.79 | $32.10M | |
| -0.08 | $14.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cynata Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cynata Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cynata Therapeutics Limited's PE Ratio?
How is the PE Ratio calculated for Cynata Therapeutics Limited (CYYNF)?
What is the highest PE Ratio for Cynata Therapeutics Limited (CYYNF)?
What is the 3-year average PE Ratio for Cynata Therapeutics Limited (CYYNF)?
What is the 5-year average PE Ratio for Cynata Therapeutics Limited (CYYNF)?
How does the current PE Ratio for Cynata Therapeutics Limited (CYYNF) compare to its historical average?